Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway

Clinical Microbiology and Infection

Volumn 16, Issue 2, 2010, Pages 171-178

  Naseer, U ^a   Haldorsen, B ^a   Simonsen, G S ^a,b,c   Sundsfjord, A ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

CMY 2; IncI1; Plasmid mediated AmpC lactamases; ST131; ST38

Indexed keywords

AZTREONAM; BETA LACTAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE CLUSTER; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NORWAY; PHENOTYPE; PHYLOGENY; PLASMID; PRIORITY JOURNAL; REPLICON;

ESCHERICHIA COLI;

EID: 74549152173     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02861.x     Document Type: Article

References (34)

1. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 2002, 46:1-11.
2. Lee K, Yong D, Choi YS. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Int J Antimicrob Agents 2007, 29:201-206.
3. Gazouli M, Kaufmann ME, Tzelepi E, Dimopoulou H, Paniara O, Tzouvelekis LS. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J Clin Microbiol 1997, 35:508-510.
4. M'Zali FH, Heritage J, Gascoyne-Binzi DM, Denton M, Todd NJ, Hawkey PM. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. J Antimicrob Chemother 1997, 40:823-831.
5. Bauernfeind A, Stemplinger I, Jungwirth R, Wilhelm R, Chong Y. Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta-lactamase genes. Antimicrob Agents Chemother 1996, 40:1926-1930.
6. Kang MS, Besser TE, Call DR. Variability in the region downstream of the blaCMY-2 beta-lactamase gene in Escherichia coli and Salmonella enterica plasmids. Antimicrob Agents Chemother 2006, 50:1590-1593.
7. Hopkins KL, Liebana E, Villa L, Batchelor M, Threlfall EJ, Carattoli A. Replicon typing of plasmids carrying CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob Agents Chemother 2006, 50:3203-3206.
8. Verdet C, Arlet G, Barnaud G, Lagrange PH, Philippon A. A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla (DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother 2000, 44:222-225.
9. Haldorsen B, Aasnaes B, Dahl KH. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. J Antimicrob Chemother 2008, 62:694-702.
10. Mammeri H, Eb F, Berkani A, Nordmann P. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J Antimicrob Chemother 2008, 61:498-503.
11. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000, 38:1791-1796.
12. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
13. Tofteland S, Haldorsen B, Dahl KH. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 2007, 45:199-205.
14. Arduino SM, Roy PH, Jacoby GA, Orman BE, Pineiro SA, Centron D. blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob Agents Chemother 2002, 46:2303-2306.
15. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2002, 66:4555-4558.
16. Naseer U, Natas OB, Haldorsen BC. Nosocomial outbreak of CTX-M-15-producing E. coli in Norway. APMIS 2007, 115:120-126.
17. Wirth T, Falush D, Lan R. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006, 60:1136-1151.
18. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999, 41:95-98.
19. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219-228.
20. Barton BM, Harding GP, Zuccarelli AJ. A general method for detecting and sizing large plasmids. Anal Biochem 1995, 226:235-240.
21. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. 2007, NORM/NORM-VET, Tromsø/Oslo 2008 ISSN:1502-2307
22. Walther-Rasmussen J, Hoiby N. Plasmid-borne AmpC beta-lactamases. Can J Microbiol 2002, 48:479-493.
23. Li Y, Li Q, Du Y. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China. J Clin Microbiol 2008, 46:1317-1321.
24. Hopkins KL, Batchelor MJ, Liebana E, heer-Graham AP, Threlfall EJ. Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales. Int J Antimicrob Agents 2006, 28:180-192.
25. Poirel L, Lartigue MF, Decousser JW, Nordmann P. ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli. Antimicrob Agents Chemother 2005, 49:447-450.
26. Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2009, 63:72-79.
27. D'Andrea MM, Nucleo E, Luzzaro F. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. Antimicrob Agents Chemother 2006, 50:618-624.
28. Lau SH, Kaufmann ME, Livermore DM. UK epidemic Escherichia coli strains A-E, with CTX-M-15 {beta}-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 2008, 62:1241-1244.
29. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 61:273-281.
30. Lau SH, Reddy S, Cheesbrough J. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 2008, 46:1076-1080.
31. Jones GL, Warren RE, Skidmore SJ, Davies VA, Gibreel T, Upton M. Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases. J Antimicrob Chemother 2008, 62:1245-1251.
32. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008, 46:2605-2612.
33. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008, 46:3900-3905.
34. Coque TM, Novais A, Carattoli A. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 2008, 14:195-200.